aluates Reports

$ 0.0

Automative

Infectious Disease In Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-5W12595

Global Infectious Disease In Vitro Diagnostics Market Research Report 2022

BUY CHAPTERS

Infectious Disease In Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5W12595

Report

December 2024

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Qiagen NV

BioMérieux SA

F Hoffmann La Roche Ltd

Hologic, Inc. (Gen Probe)

Abbott

Quidel Corp.

Siemens Healthineers AG

Bio-Rad Laboratories Inc

Danaher Corp

Orasure Technologies, Inc.

Infectious Disease In Vitro Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Infectious Disease In Vitro Diagnostics - Market

The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.

The global market for Infectious Disease In Vitro Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Disease In Vitro Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease In Vitro Diagnostics by region & country, by Type, and by Application.

The Infectious Disease In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In Vitro Diagnostics.

Market Segmentation

Scope of Infectious Disease In Vitro Diagnostics - Market Report

Report Metric	Details
Report Name	Infectious Disease In Vitro Diagnostics - Market
CAGR	5%
Segment by Type:	Instruments Reagents
Segment by Application	Hospitals & Clinics Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., OraSure Technologies, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease In Vitro Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease In Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease In Vitro Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Infectious Disease In Vitro Diagnostics - Market report?

Ans: The main players in the Infectious Disease In Vitro Diagnostics - Market are QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., OraSure Technologies, Inc.

What are the Application segmentation covered in the Infectious Disease In Vitro Diagnostics - Market report?

Ans: The Applications covered in the Infectious Disease In Vitro Diagnostics - Market report are Hospitals & Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Infectious Disease In Vitro Diagnostics - Market report?

Ans: The Types covered in the Infectious Disease In Vitro Diagnostics - Market report are Instruments, Reagents

Recommended Reports

In Vitro Diagnostics

Infectious Disease Diagnostics

Disease-Specific Testing

1 Market Overview

1.1 Infectious Disease In Vitro Diagnostics Product Introduction

1.2 Global Infectious Disease In Vitro Diagnostics Market Size Forecast

1.3 Infectious Disease In Vitro Diagnostics Market Trends & Drivers

1.3.1 Infectious Disease In Vitro Diagnostics Industry Trends

1.3.2 Infectious Disease In Vitro Diagnostics Market Drivers & Opportunity

1.3.3 Infectious Disease In Vitro Diagnostics Market Challenges

1.3.4 Infectious Disease In Vitro Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infectious Disease In Vitro Diagnostics Players Revenue Ranking (2023)

2.2 Global Infectious Disease In Vitro Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Infectious Disease In Vitro Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Infectious Disease In Vitro Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Infectious Disease In Vitro Diagnostics

2.6 Infectious Disease In Vitro Diagnostics Market Competitive Analysis

2.6.1 Infectious Disease In Vitro Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Infectious Disease In Vitro Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Instruments

3.1.2 Reagents

3.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Type

3.2.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Infectious Disease In Vitro Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Infectious Disease In Vitro Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals & Clinics

4.1.2 Diagnostic Laboratories

4.1.3 Others

4.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Application

4.2.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Infectious Disease In Vitro Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Infectious Disease In Vitro Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Region

5.1.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

5.2.2 North America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

5.3.2 Europe Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

5.5.2 South America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value

6.3 United States

6.3.1 United States Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.3.2 United States Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.4.2 Europe Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.5.2 China Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.6.2 Japan Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030

6.9.2 India Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 QIAGEN

7.1.1 QIAGEN Profile

7.1.2 QIAGEN Main Business

7.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.1.4 QIAGEN Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 QIAGEN Recent Developments

7.2 BD

7.2.1 BD Profile

7.2.2 BD Main Business

7.2.3 BD Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.2.4 BD Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 BD Recent Developments

7.3 bioMérieux SA

7.3.1 bioMérieux SA Profile

7.3.2 bioMérieux SA Main Business

7.3.3 bioMérieux SA Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.3.4 bioMérieux SA Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 F. Hoffmann-La Roche, Ltd. Recent Developments

7.4 F. Hoffmann-La Roche, Ltd.

7.4.1 F. Hoffmann-La Roche, Ltd. Profile

7.4.2 F. Hoffmann-La Roche, Ltd. Main Business

7.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.4.4 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 F. Hoffmann-La Roche, Ltd. Recent Developments

7.5 Hologic, Inc. (Gen-Probe)

7.5.1 Hologic, Inc. (Gen-Probe) Profile

7.5.2 Hologic, Inc. (Gen-Probe) Main Business

7.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.5.4 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Hologic, Inc. (Gen-Probe) Recent Developments

7.6 Abbott

7.6.1 Abbott Profile

7.6.2 Abbott Main Business

7.6.3 Abbott Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.6.4 Abbott Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 Abbott Recent Developments

7.7 Quidel Corp.

7.7.1 Quidel Corp. Profile

7.7.2 Quidel Corp. Main Business

7.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.7.4 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Quidel Corp. Recent Developments

7.8 Siemens Healthineers AG

7.8.1 Siemens Healthineers AG Profile

7.8.2 Siemens Healthineers AG Main Business

7.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.8.4 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Siemens Healthineers AG Recent Developments

7.9 Bio-Rad Laboratories, Inc.

7.9.1 Bio-Rad Laboratories, Inc. Profile

7.9.2 Bio-Rad Laboratories, Inc. Main Business

7.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.9.4 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Bio-Rad Laboratories, Inc. Recent Developments

7.10 Danaher Corp.

7.10.1 Danaher Corp. Profile

7.10.2 Danaher Corp. Main Business

7.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.10.4 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 Danaher Corp. Recent Developments

7.11 OraSure Technologies, Inc.

7.11.1 OraSure Technologies, Inc. Profile

7.11.2 OraSure Technologies, Inc. Main Business

7.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

7.11.4 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)

7.11.5 OraSure Technologies, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Infectious Disease In Vitro Diagnostics Industrial Chain

8.2 Infectious Disease In Vitro Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Infectious Disease In Vitro Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Infectious Disease In Vitro Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Qiagen NV

BioMérieux SA

F Hoffmann La Roche Ltd

Hologic, Inc. (Gen Probe)

Abbott

Quidel Corp.

Siemens Healthineers AG

Bio-Rad Laboratories Inc

Danaher Corp

Orasure Technologies, Inc.

List of Tables

Table 1. Infectious Disease In Vitro Diagnostics Market Trends

Table 2. Infectious Disease In Vitro Diagnostics Market Drivers & Opportunity

Table 3. Infectious Disease In Vitro Diagnostics Market Challenges

Table 4. Infectious Disease In Vitro Diagnostics Market Restraints

Table 5. Global Infectious Disease In Vitro Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Infectious Disease In Vitro Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Infectious Disease In Vitro Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Infectious Disease In Vitro Diagnostics

Table 10. Global Infectious Disease In Vitro Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Infectious Disease In Vitro Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Infectious Disease In Vitro Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Infectious Disease In Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. QIAGEN Basic Information List

Table 32. QIAGEN Description and Business Overview

Table 33. QIAGEN Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of QIAGEN (2019-2024)

Table 35. QIAGEN Recent Developments

Table 36. BD Basic Information List

Table 37. BD Description and Business Overview

Table 38. BD Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of BD (2019-2024)

Table 40. BD Recent Developments

Table 41. bioMérieux SA Basic Information List

Table 42. bioMérieux SA Description and Business Overview

Table 43. bioMérieux SA Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of bioMérieux SA (2019-2024)

Table 45. bioMérieux SA Recent Developments

Table 46. F. Hoffmann-La Roche, Ltd. Basic Information List

Table 47. F. Hoffmann-La Roche, Ltd. Description and Business Overview

Table 48. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of F. Hoffmann-La Roche, Ltd. (2019-2024)

Table 50. F. Hoffmann-La Roche, Ltd. Recent Developments

Table 51. Hologic, Inc. (Gen-Probe) Basic Information List

Table 52. Hologic, Inc. (Gen-Probe) Description and Business Overview

Table 53. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Hologic, Inc. (Gen-Probe) (2019-2024)

Table 55. Hologic, Inc. (Gen-Probe) Recent Developments

Table 56. Abbott Basic Information List

Table 57. Abbott Description and Business Overview

Table 58. Abbott Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Abbott (2019-2024)

Table 60. Abbott Recent Developments

Table 61. Quidel Corp. Basic Information List

Table 62. Quidel Corp. Description and Business Overview

Table 63. Quidel Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Quidel Corp. (2019-2024)

Table 65. Quidel Corp. Recent Developments

Table 66. Siemens Healthineers AG Basic Information List

Table 67. Siemens Healthineers AG Description and Business Overview

Table 68. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Siemens Healthineers AG (2019-2024)

Table 70. Siemens Healthineers AG Recent Developments

Table 71. Bio-Rad Laboratories, Inc. Basic Information List

Table 72. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 73. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Bio-Rad Laboratories, Inc. (2019-2024)

Table 75. Bio-Rad Laboratories, Inc. Recent Developments

Table 76. Danaher Corp. Basic Information List

Table 77. Danaher Corp. Description and Business Overview

Table 78. Danaher Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Danaher Corp. (2019-2024)

Table 80. Danaher Corp. Recent Developments

Table 81. OraSure Technologies, Inc. Basic Information List

Table 82. OraSure Technologies, Inc. Description and Business Overview

Table 83. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions

Table 84. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of OraSure Technologies, Inc. (2019-2024)

Table 85. OraSure Technologies, Inc. Recent Developments

Table 86. Key Raw Materials Lists

Table 87. Raw Materials Key Suppliers Lists

Table 88. Infectious Disease In Vitro Diagnostics Downstream Customers

Table 89. Infectious Disease In Vitro Diagnostics Distributors List

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

Table 93. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Infectious Disease In Vitro Diagnostics Product Picture

Figure 2. Global Infectious Disease In Vitro Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Infectious Disease In Vitro Diagnostics Report Years Considered

Figure 5. Global Infectious Disease In Vitro Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease In Vitro Diagnostics Revenue in 2023

Figure 7. Infectious Disease In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Instruments Picture

Figure 9. Reagents Picture

Figure 10. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Infectious Disease In Vitro Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospitals & Clinics

Figure 13. Product Picture of Diagnostic Laboratories

Figure 14. Product Picture of Others

Figure 15. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Infectious Disease In Vitro Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value (%), (2019-2030)

Figure 28. United States Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 34. China Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 36. China Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 46. India Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 48. India Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 49. Infectious Disease In Vitro Diagnostics Industrial Chain

Figure 50. Infectious Disease In Vitro Diagnostics Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

In Vitro Diagnostics Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Disease Testing And Diagnostic Market Research Report 2024

Healthcare associated Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI In Vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnosis IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostics IVD Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Devices for Diagnostics in Vitro Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

In Vitro Assays to Diagnose Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Infectious Disease Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In vitro Diagnostics IVD Instruments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Diagnostics Systems Market Insights Forecast to 2030

In Vitro Diagnostic Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Rapid Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostic Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Disease Biomarker Testing Market Research Report 2024

Global IVD Infectious Diseases Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions